Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 49Pancreatic Neoplasms 33Prostatic Neoplasms 31Brain Neoplasms 28Lung Neoplasms 26Neoplasm Metastasis 24Melanoma 21Carcinoma, Hepatocellular 20Breast Neoplasms 16Carcinoma, Renal Cell 12Colorectal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Neoplasms 9Small Cell Lung Carcinoma 7Urinary Bladder Neoplasms 5Recurrence 5Head and Neck Neoplasms 5Glioblastoma 5Adenocarcinoma of Lung 5Sarcoma 4Liver Neoplasms 4Kidney Neoplasms 4Uterine Cervical Neoplasms 3NSCLC 3Clear-cell metastatic renal cell carcinoma 3Cholangiocarcinoma 3Uveal Melanoma 2Unresectable Locally Recurrent Rectal Cancer 2Rectal Neoplasms 2Ovarian Neoplasms 2

Interventions

enzalutamide 4cabazitaxel 3Docetaxel 3Prednisone 2talazoparib 1rucaparib 1pembrolizumab 1olaparib 1Zuclomiphene 1XRP6258 1Standard of Care 1Radiosurgery 1Positron Emission Tomography Computed Tomography 1LY3023414 1Injections 1Carboplatin 1Abituzumab 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostate Cancer Metastatic × Radiosurgery × Clear all
NCT06251492 2024-02-20

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Fudan University

Phase 2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡